GCP
ROCM

GSA Capital Partners’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

GSA Capital Partners’s Portfolio ROCM Stock Details ROCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-21,899
Closed -$323K – 1763
2013
Q2 		$323K Buy
+21,899
New +$313K 0.04% 834

Other funds holding ROCM

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
PGIM
Pacific Global Investment Management Glendale, California $70.7M AUM 14.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSA Capital Partners's ROCM Position: Q3 2013 in Review

GSA Capital Partners sold out of ROCHESTER MEDICAL CORP (ROCM) in Q3 2013, closing a stake of 21,899 shares — an estimated $323K sold.

GSA Capital Partners first reported a position in ROCM in Q2 2013 and held it in 1 quarter. The position peaked at $323K in Q2 2013. 68 funds tracked by Wall St. Rank hold ROCM as of Q3 2013.

  • GSA Capital Partners reported no remaining ROCHESTER MEDICAL CORP position as of Q3 2013 after selling out during the quarter.
  • GSA Capital Partners sold 21,899 ROCHESTER MEDICAL CORP shares in Q3 2013, an estimated $323K.
  • GSA Capital Partners first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 1 quarter.
  • GSA Capital Partners's ROCHESTER MEDICAL CORP position peaked at $323K in Q2 2013.
  • 68 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q3 2013.

Based on GSA Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.